Nektar Therapeutics (NASDAQ:NKTR)

Wednesday’s trading has closed, but NKTR is being traded in the after-hours session. After-Hours quote »
13.39
Delayed Data
As of 4:00pm ET
 +0.45 / +3.48%
Today’s Change
10.10
Today|||52-Week Range
17.53
-13.61%
Year-to-Date

Today’s Trading

Previous close12.94
Today’s open12.93
Day’s range12.80 - 13.43
Volume1,166,638
Average volume (3 months)980,434
Market cap$1.7B
Dividend yield--
Data as of 4:00pm ET, 03/04/2015

Growth & Valuation

Earnings growth (last year)+70.00%
Earnings growth (this year)-8.93%
Earnings growth (next 5 years)+42.46%
Revenue growth (last year)+34.77%
P/E ratioNM
Price/Sales9.80
Price/Book--

Competitors

 Today’s
change
Today’s
% change
FGENFibroGen Inc-0.69-2.27%
INCRINC Research Holding...-0.16-0.54%
PRAHPRA Health Sciences ...+0.08+0.26%
ARIAARIAD Pharmaceutical...+0.15+1.89%
Data as of 4:00pm ET, 03/04/2015

Financials

Next reporting dateMay 6, 2015
EPS forecast (this quarter)-$0.40
Annual revenue (last year)$200.7M
Annual profit (last year)-$53.9M
Net profit margin-26.86%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Class I Director
Howard W. Robin
Chief Financial Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account